Pfizer: Undervalued Healthcare Leader Poised for Further Recovery (NYSE:PFE)

JR Research is an opportunistic investor. He has been recognized by TipRanks as a top analyst. He has also been recognized by Seeking Alpha as a “Top Analyst to Watch” for Technology, Software and Internet, as well as Growth and GARP.

He identifies attractive risk/reward opportunities backed by robust price action to potentially generate alpha well above the S&P 500. He has also demonstrated superior performance with his picks.

He focuses on identifying growth investment opportunities that present the most attractive risk/reward growth potential. His approach combines sharp price action analysis with fundamental investing.

He tends to avoid overvalued and overvalued stocks, while capitalizing on damaged stocks with significant recovery potential.

He leads the investment group Ultimate Growth Investing, which specializes in identifying high-potential opportunities in various sectors. He focuses on ideas that have strong growth potential and well-beaten counter pieces, with an 18- to 24-month outlook for the thesis to unfold.

The group is designed for investors looking to capitalize on growth stocks with strong fundamentals, buying momentum and turnaround plays at very attractive valuations.

Learn more